Siddhartha Mukherjee, MD, DPhil
Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
About Siddhartha Mukherjee
Hematologist and oncologist Siddhartha Mukherjee was born in New Delhi, India. He holds a BS in biology from Stanford University, a DPhil in immunology from Oxford University (where he was a Rhodes Scholar), and an MD from Harvard Medical School. He completed his internal medicine residency and an oncology fellowship at Massachusetts General Hospital. Dr. Murkherjee is an assistant professor of medicine at Columbia University Medical Center. He lives in Manhattan with his wife, artist Sarah Sze, and their two daughters.
His Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, tells the story of cancer from its first description in an ancient Egyptian scroll to the gleaming laboratories of modern research institutions. A three-part documentary series based on the book, directed by Barak Goodman and executive produced by Ken Burns, debuts on PBS stations March 30 and continues on March 31 and April 1. The film interweaves a sweeping historical narrative with intimate stories about contemporary patients and an investigation into the latest scientific breakthroughs.
Academic Titles
- Assistant Professor of Medicine
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Signature Administrators
- Student Health
AgeWell
- Medicare Managed Care
- Special Needs Plan
Amida Care
- Special Needs Plan
Capital District Physician Health Plan
- Capital District Physician Health Plan
Emblem/GHI
- Medicare Managed Care
- PPO
MagnaCare
- MagnaCare
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
UnitedHealthcare
- Columbia University Employee Plan
VNSNY CHOICE
- Medicare Managed Care
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Research
Dr. Mukherjee’s research lab studies the biology of blood development, in particular, malignant and pre-malignant diseases such as myelodysplasia (MDS) and acute myelogenous leukemia (AML). The eventual goal is to develop novel drugs against these diseases.
Grants
TARGETING SPLICING FACTOR MUTATIONS IN MYELDYSPLASTIC SYNDROMES IN CANCER (Private)
Jun 1 2018 - May 31 2021
COMBINING IMMUNOTOXIN-BASED CONDITIONING AND ADC WITH ALLOGENEIC HSCT: A TWO-HIT ON LEUKEMIA APPROACH (Private)
Jan 1 2020 - Dec 31 2020
OSTEOCHONDRORETICULAR (OCR) CELLS AS SOURCES OF CARTILAGE REPAIR IN OSTEOARTHRITIS (Federal Gov)
Jul 1 2016 - Jun 30 2020
ENGINEERING CAR-TARGETED, CD94/NKG2A NULL NK CELLS FOR SAFER AND MORE EFFICIENT EFFECTOR IMMUNE CELLS (Private)
Jul 1 2019 - Jan 31 2020
A PHASE 1 TRIAL OF PERSONALIZED/PRECISION THERAPEUTICS FOR MYELODYSPLASTIC SYNDROME (MDS) USING BONE MARROW ORGANOID (BM-O) SCREENING (Private)
Apr 1 2016 - Mar 31 2019
PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITION TO TREAT PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL) (Private)
Feb 26 2016 - Feb 25 2019
YES 1 AND CTNND1 AS QUIESCENCE REGULATORS IN HEMATOPOIETIC STEM CELLS (Federal Gov)
Aug 1 2013 - Apr 30 2018
YES 1 AND CTNND1 AS QUIESCENCE REGULATORS IN HEMATOPOIETIC STEM CELLS (Federal Gov)
Aug 1 2013 - Apr 30 2018
YES 1 AND CTNND1 AS QUIESCENCE REGULATORS IN HEMATOPOIETIC STEM CELLS (Federal Gov)
Aug 1 2013 - Apr 30 2018
CHIMERIC ANTIGEN T CELL THERAPIES IN ACUTE MYELOID LEUKEMIA (Private)
Apr 29 2016 - Apr 28 2018
CLINICAL ANNOTATION AND PERSONALIZED TREATMENT FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES (Private)
Nov 1 2014 - Oct 31 2016
CENTER FOR HIGH-THROUGHPUT MINIMALLY-INVASIVE RADIATION BIODOSIMETRY (Federal Gov)
Aug 31 2005 - Jul 31 2016
THE ROLE OF XLF IN HEMATOPOIETIC STEM CELL MAINTENANCE AND FUNCTION (Federal Gov)
Aug 15 2013 - Jul 31 2015
THE ROLE OF XLF IN HEMATOPOIETIC STEM CELL MAINTENANCE AND FUNCTION (Federal Gov)
Aug 15 2013 - Jul 31 2015
ILLUMINATE THE PATHOPHYSIOLOGY OF MDS WITH SRSF2 (Private)
Jul 1 2014 - Jun 30 2015
EXOME AND NEXT GENERATION SEQUENCING TO IDENTIFY RARS-SPECIFIC TARGETABLE DEFECTS (Private)
Jul 1 2012 - Jun 30 2014
COLLABORATIVE EFFORT IN STEM CELL BIOLOGY (Private)
Jul 1 2010 - Jun 30 2014
CANCER STEM CELL SPECIFIC LETHALITY IN ACUTE MYELOID LEUKEMIA STEM CELLS BY MODULATION OF PES-1 AND DFFB (Private)
Jan 1 2012 - Dec 31 2013
DISSECTING THE ROLES OF YES-1, MIIT3 AND CTNND1 IN LEUKEMIA STEM CELL QUIESCENCE (Private)
Jan 1 2011 - Dec 31 2013
IDENTIFICATION OF FUNCTIONAL TUMOR-STROMAL INTERACTIONS IN T HE BONE MARROW (Federal Gov)
Sep 30 2009 - Aug 31 2012
THE REGULATION OF LEUKEMIA-ENGRAFTING CELLS BY THE HEMATOPOE ITIC STEM CELL NICHE (Federal Gov)
Sep 30 2006 - Jul 31 2011